key: cord-0768539-amalp1pt authors: Arora, Aakanksha; Mohta, Alpana; Ghiya, Bhikam Chand; Kumar Jangir, Vishnu title: Acute postinfectious type III pityriasis rubra pilaris as a cutaneous manifestation in COVID‐19: Decoding a possible trigger!! date: 2022-04-09 journal: J Cosmet Dermatol DOI: 10.1111/jocd.14933 sha: 2b58726d95752a6342216b6d8622743b93e0c335 doc_id: 768539 cord_uid: amalp1pt nan To the Editor, The clinical spectrum of COVID-19-induced skin manifestations in the literature includes urticarial rash, maculopapular rash, morbilliform rash, papulovesicular exanthem, chilblain-like acral pattern, livedo reticularis/racemosa-like pattern, and purpuric "vasculitic" pattern. 1 Pityriasis rubra pilaris (PRP) is a rare, idiopathic inflammatory papulosquamous disorder. Infection, autoimmunity, drugs, and malignancies can be triggers for PRP. 2 Herein, we report a pediatric case of pityriasis rubra pilaris post-COVID-19 infection. In conclusion, the association between COVID-19 and PRP may not be just coincidental because viral agents have been proposed to be a trigger in PRP pathogenesis. Further research is needed to confirm the correlation between SARS-CoV-2 infection and PRP. Due ethical approval was taken from institutional ethics committee. The patient gave written informed consent to be a part of this study. Data sharing is not applicable to this article as no new data were created or analyzed in this study. Skin manifestations associated with COVID-19: current knowledge and future perspectives Juvenile) Pityriasis rubra pilaris Pityriasis rubra pilaris: algorithms for diagnosis and treatment Acute pityriasis rubra pilaris in childhood. Four cases Acute postinfectious pityriasis rubra pilaris as a cutaneous manifestation in COVID-19: a case report and its dermoscopic features Pityriasis rubra pilaris post-infection due COVID-19: case report